Man Group PLC Amarin Corp Plcuk Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $139,302 - $212,550	-32,700 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.03 - $8.8 $164,481 - $287,760	32,700 New	32,700 $203,000
Q4 2020 Feb 16, 2021	SELL	$4.04 - $5.31 $74,958 - $98,521	-18,554 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $563,639 - $1.2 Million	-154,846 Reduced 89.3%	18,554 $78,000
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $828,852 - $1.43 Million	173,400 New	173,400 $1.2 Million

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.